# Home Bancshares Inc: financial statements, quarterly

HOMB · NYSE · CIK 1331520 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/homb.md) · [Financials](/companies/homb/financials.md) · [Filings](/companies/homb/filings.md) · [Insiders](/companies/homb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/homb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [92.3](/filings/0001331520-23-000070.md) | [103 d](/filings/0001331520-24-000080.md) | [112](/filings/0001331520-24-000126.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [30.8](/filings/0001331520-24-000178.md) | [26.6 d](/filings/0001331520-26-000051.md) | [30.3](/filings/0001331520-25-000107.md) | [31.9](/filings/0001331520-25-000135.md) | [29.0](/filings/0001331520-25-000148.md) | [28.9 d](/filings/0001331520-26-000051.md) | [31.9](/filings/0001331520-26-000095.md) | [33.6](/filings/0001331520-26-000112.md) | [35.7](/filings/0001331520-25-000148.md) | [35.1 d](/filings/0001331520-26-000051.md) | [34.0](/filings/0001331520-26-000095.md) | [35.1](/filings/0001331520-26-000112.md) |
| Net income | $m | [98.5](/filings/0001331520-24-000178.md) | [86.2 d](/filings/0001331520-26-000051.md) | [100](/filings/0001331520-25-000148.md) | [102](/filings/0001331520-25-000148.md) | [100](/filings/0001331520-25-000148.md) | [101 d](/filings/0001331520-26-000051.md) | [115](/filings/0001331520-26-000112.md) | [118](/filings/0001331520-26-000112.md) | [124](/filings/0001331520-25-000148.md) | [118 d](/filings/0001331520-26-000051.md) | [118](/filings/0001331520-26-000112.md) | [119](/filings/0001331520-26-000112.md) |
| Diluted EPS | $ per share | [0.49](/filings/0001331520-24-000178.md) | not reported | [0.50](/filings/0001331520-25-000107.md) | [0.51](/filings/0001331520-25-000135.md) | [0.50](/filings/0001331520-25-000148.md) | not reported | [0.58](/filings/0001331520-26-000095.md) | [0.60](/filings/0001331520-26-000112.md) | [0.63](/filings/0001331520-25-000148.md) | not reported | [0.60](/filings/0001331520-26-000095.md) | [0.59](/filings/0001331520-26-000112.md) |
| Basic EPS | $ per share | [0.49](/filings/0001331520-24-000178.md) | not reported | [0.50](/filings/0001331520-25-000107.md) | [0.51](/filings/0001331520-25-000135.md) | [0.50](/filings/0001331520-25-000148.md) | not reported | [0.58](/filings/0001331520-26-000095.md) | [0.60](/filings/0001331520-26-000112.md) | [0.63](/filings/0001331520-25-000148.md) | not reported | [0.60](/filings/0001331520-26-000095.md) | [0.59](/filings/0001331520-26-000112.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0001331520-23-000070.md) | [1.0](/filings/0001331520-25-000076.md) | [1.2](/filings/0001331520-24-000126.md) | [1.1](/filings/0001331520-24-000164.md) | [1.0](/filings/0001331520-24-000178.md) | [0.9](/filings/0001331520-26-000051.md) | [1.3](/filings/0001331520-25-000107.md) | [1.1](/filings/0001331520-25-000135.md) | [0.8](/filings/0001331520-25-000148.md) | [0.7](/filings/0001331520-26-000112.md) | [1.1](/filings/0001331520-26-000095.md) | [1.1](/filings/0001331520-26-000112.md) |
| Total assets | $bn | [22.0](/filings/0001331520-23-000070.md) | [22.7](/filings/0001331520-25-000076.md) | [22.8](/filings/0001331520-24-000126.md) | [22.9](/filings/0001331520-24-000164.md) | [22.8](/filings/0001331520-24-000178.md) | [22.5](/filings/0001331520-26-000051.md) | [23.0](/filings/0001331520-25-000107.md) | [22.9](/filings/0001331520-25-000135.md) | [22.7](/filings/0001331520-25-000148.md) | [22.9](/filings/0001331520-26-000112.md) | [23.2](/filings/0001331520-26-000095.md) | [24.7](/filings/0001331520-26-000112.md) |
| Total liabilities | $bn | [18.3](/filings/0001331520-23-000070.md) | [18.9](/filings/0001331520-25-000076.md) | [19.0](/filings/0001331520-24-000126.md) | [19.1](/filings/0001331520-24-000164.md) | [18.9](/filings/0001331520-24-000178.md) | [18.5](/filings/0001331520-26-000051.md) | [18.9](/filings/0001331520-25-000107.md) | [18.8](/filings/0001331520-25-000135.md) | [18.5](/filings/0001331520-25-000148.md) | [18.6](/filings/0001331520-26-000112.md) | [18.9](/filings/0001331520-26-000095.md) | [20.2](/filings/0001331520-26-000112.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [3.7](/filings/0001331520-24-000178.md) | [3.8](/filings/0001331520-26-000051.md) | [3.8](/filings/0001331520-25-000148.md) | [3.9](/filings/0001331520-25-000148.md) | [4.0](/filings/0001331520-25-000148.md) | [4.0](/filings/0001331520-26-000112.md) | [4.0](/filings/0001331520-26-000112.md) | [4.1](/filings/0001331520-26-000112.md) | [4.2](/filings/0001331520-25-000148.md) | [4.3](/filings/0001331520-26-000112.md) | [4.3](/filings/0001331520-26-000112.md) | [4.5](/filings/0001331520-26-000112.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [99.1 d](/filings/0001331520-24-000178.md) | [115 d](/filings/0001331520-26-000051.md) | [148](/filings/0001331520-25-000107.md) | [109 d](/filings/0001331520-25-000135.md) | [129 d](/filings/0001331520-25-000148.md) | [75.1 d](/filings/0001331520-26-000051.md) | [117](/filings/0001331520-26-000095.md) | [78.4 d](/filings/0001331520-26-000112.md) | [115 d](/filings/0001331520-25-000148.md) | [88.7 d](/filings/0001331520-26-000051.md) | [151](/filings/0001331520-26-000095.md) | [97.4 d](/filings/0001331520-26-000112.md) |
| Capital expenditure | $m | [8.0 d](/filings/0001331520-24-000178.md) | [5.0 d](/filings/0001331520-26-000051.md) | [1.7](/filings/0001331520-25-000107.md) | [10.2 d](/filings/0001331520-25-000135.md) | [12.4 d](/filings/0001331520-25-000148.md) | [14.3 d](/filings/0001331520-26-000051.md) | [6.9](/filings/0001331520-26-000095.md) | [8.0 d](/filings/0001331520-26-000112.md) | [2.9 d](/filings/0001331520-25-000148.md) | [4.5 d](/filings/0001331520-26-000051.md) | [11.6](/filings/0001331520-26-000095.md) | [3.3 d](/filings/0001331520-26-000112.md) |
| Dividends paid | $m | [36.5 d](/filings/0001331520-24-000178.md) | [36.3 d](/filings/0001331520-26-000051.md) | [36.2](/filings/0001331520-25-000107.md) | [36.1 d](/filings/0001331520-25-000135.md) | [38.9 d](/filings/0001331520-25-000148.md) | [38.8 d](/filings/0001331520-26-000051.md) | [38.8](/filings/0001331520-26-000095.md) | [39.5 d](/filings/0001331520-26-000112.md) | [39.4 d](/filings/0001331520-25-000148.md) | [41.3 d](/filings/0001331520-26-000051.md) | [41.3](/filings/0001331520-26-000095.md) | [42.3 d](/filings/0001331520-26-000112.md) |
| Share repurchases | $m | [5.7 d](/filings/0001331520-24-000178.md) | [17.8 d](/filings/0001331520-26-000051.md) | [24.2](/filings/0001331520-25-000107.md) | [32.9 d](/filings/0001331520-25-000135.md) | [27.0 d](/filings/0001331520-25-000148.md) | [2.5 d](/filings/0001331520-26-000051.md) | [29.8](/filings/0001331520-26-000095.md) | [27.5 d](/filings/0001331520-26-000112.md) | [10.0 d](/filings/0001331520-25-000148.md) | [14.9 d](/filings/0001331520-26-000051.md) | [13.9](/filings/0001331520-26-000095.md) | [40.8 d](/filings/0001331520-26-000112.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [205](/filings/0001331520-23-000070.md) | [204](/filings/0001331520-24-000126.md) | [203](/filings/0001331520-24-000164.md) | [203](/filings/0001331520-24-000178.md) | [201](/filings/0001331520-25-000107.md) | [200](/filings/0001331520-25-000135.md) | [199](/filings/0001331520-25-000148.md) | [199](/filings/0001331520-26-000095.md) | [198](/filings/0001331520-26-000112.md) | [197](/filings/0001331520-25-000148.md) | [197](/filings/0001331520-26-000095.md) | [201](/filings/0001331520-26-000112.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 200,049,630 at 2026-08-06, from the cover of the [10-Q filed 2026-08-07](/filings/0001331520-26-000112.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.